J. Collins

发表

Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus

D. Bolognesi, P. H. Atkinson, J. Leis, 1975, Journal of virology.

Immunotherapy of murine leukemia. VII. Prevention of friend leukemia virus‐induced immunosuppression by passive serum therapy

E. Genovesi, D. Livnat, J. Collins, 1982, International journal of cancer.

The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit.

A. Tryka, J. K. Koster, J. Collins, 1981, Artery.

Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.

C. Kirman, J. Klaunig, M. Gargas, 2005, Regulatory toxicology and pharmacology : RTP.

Subchronic Toxicity Studies of t-Butyl Alcohol in Rats and Mice

R. Maronpot, C. Lindamood, D. Farnell, 1992 .

Bacteriology of acute otitis media in adults.

C. Bluestone, J. Collins, J. Stephenson, 1991, JAMA.

Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy.

E. Genovesi, D. Livnat, F. Sanfilippo, 1981, Cancer research.

Screening-Level Risk Assessment for Styrene-Acrylonitrile (SAN) Trimer Detected in Soil and Groundwater

C. Kirman, M. Gargas, J. Rowlands, 2012, Journal of toxicology and environmental health. Part A.

Erratum to: Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

D. Henry, G. Giguere, J. Collins, 1999 .

Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

D. Henry, G. Giguere, J. Collins, 1999 .

The SV40 "S" antigen and other papovavirus-induced surface antigens.

P. Black, J. Collins, 1974, Current topics in microbiology and immunology.

A review of adverse pregnancy outcomes and formaldehyde exposure in human and animal studies.

R. Tyl, R. Ness, N. Krivanek, 2001, Regulatory toxicology and pharmacology : RTP.

Reproductive effects of theophylline in mice and rats.

D. Gulati, J. Lamb, R. Morrissey, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Immunotherapy of murine leukemia. XI. Differential susceptibility of spleen cells from serum‐protected mice to the in vitro immunosuppressive effects of friend leukemia virus‐infected splenocytes

C. Pettey, J. Collins, Carolyn L. Pettey, 1984, International journal of cancer.

Subchronic toxicity of orally administered (gavage and dosed-feed) theophylline in Fischer 344 rats and B6C3F1 mice.

J. E. Heath, M. Elwell, J. Lamb, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Isolation of simian virus 40-transformed inbred hamster cell lines heterogeneous for virus induction by chemicals or radiation.

P. Black, J. Kaplan, J. Collins, 1975, Virology.

Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.

R. Snyderman, J. Collins, 1980, Cancer research.

CNS tumors and exposure to acrylonitrile: inconsistency between experimental and epidemiology studies.

J. Collins, D. Strother, 1999, Neuro-oncology.

Mouse strains for chemical carcinogenicity studies: overview of a workshop.

L S Birnbaum, R. Tennant, L. Birnbaum, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Toxicological evaluation of 4-vinylcyclohexene. II. Induction of ovarian tumors in female B6C3F1 mice by chronic oral administration of 4-vinylcyclohexene.

J. Collins, A. G. Manus, R. Montali, 1987, Journal of toxicology and environmental health.

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

R. Nadelman, G. Wormser, J. Collins, 1992, Annals of Internal Medicine.

Role of carbohydrate in biological functions of Friend murine leukemia virus gp71

D. Bolognesi, P. Fischinger, J. Collins, 1977, Journal of virology.

Immunotherapy of murine leukemia. I. protection against friend leukemia virus‐induced disease by passive serum therapy

R. Metzgar, F. Sanfilippo, J. Collins, 1978, International journal of cancer.

Subchronic toxicity of orally administered (gavage and dosed-feed) theophylline in fischer 344 rats and B6C3F1 mice

J. E. Heath, M. Elwell, J. Collins, 1988 .

Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice.

M. Hanna, J. Ihle, D. Bolognesi, 1976, Virology.

In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of friend leukemia virus

E. Genovesi, J. Collins, 1983, Journal of cellular physiology.

Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy.

E. Genovesi, D. Livnat, J. Collins, 1982, Leukemia research.

Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.

M. Hanna, J. Ihle, D. Bolognesi, 1976, Virology.

Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells

D. Bolognesi, T. Denny, J. Collins, 1977, Journal of virology.

Insecticides, Herbicides, and Rodenticides

James G. Adams, A. Ruha, J. Collins, 2008 .

Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens

I. M. Davis, T. L. Lloyd, J. Powell, 1991, Antimicrobial Agents and Chemotherapy.

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

R. Nadelman, G. Wormser, E. Grunwaldt, 1995, Antimicrobial agents and chemotherapy.

Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: evidence for synthesis of immunoglobulin by the transformed cells.

E. Haber, A. Strosberg, P. Black, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.

S. Spector, R. Cobo, G. Giguere, 1992, The American journal of medicine.

Specificity of the carcinoembryonic antigen (CEA).

P. Black, J. Collins, 1971, The New England journal of medicine.

Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents

R. C. Johnson, J. Collins, P. Jurkovich, 1990, Antimicrobial Agents and Chemotherapy.

Antibiotic prophylaxis during clean neurosurgery: a large, multicenter study using cefuroxime.

K. Holloway, J. Wilberger, G. Giguere, 1996, Clinical therapeutics.

ALLOGENEIC REACTIVITY IN NORMAL MOUSE SERUM

E. Rinchik, M. Lynes, J. Collins, 1984, Journal of immunogenetics.

Pituitary and Thyroid Gland Lesions Induced by 2-Mercaptobenzimidazole (2-MBI) Inhalation in Male Fischer-344 Rats

J. Cullen, D. Norford, D. Meuten, 1993, Toxicologic pathology.

Toxicological evaluation of 4-vinylcyclohexene. I. Prechronic (14-day) and subchronic (13-week) gavage studies in Fischer 344 rats and B6C3F1 mice.

J. Collins, A. G. Manus, 1987, Journal of toxicology and environmental health.

Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.

J. Feris, G. Giguere, J. Collins, 1996, The Journal of antimicrobial chemotherapy.

Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains

J. Schwebke, E. Hook, A. Rompalo, 1996, Antimicrobial agents and chemotherapy.

Pharmacokinetics ofCefuroxime Axetil andCefaclor: Relationship ofConcentrations inSerumtoMICsfor CommonRespiratory Pathogens

I. M. Davis, T. L. Lloyd, J. Powell, 1991 .

Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children.

K. Sherin, L. Feld, A. Kornberg, 1994, American journal of nephrology.

Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.

R. Schwartz, W. Gooch, R. Yetman, 1996, The Pediatric infectious disease journal.

Subchronic toxicity studies of t-butyl alcohol in rats and mice.

R. Maronpot, C. Lindamood, K. Takahashi, 1992, Fundamental and Applied Toxicology.

Chromosomally depleted interspecific hybrid cell clones selected with cytotoxic antisera: utilization in the study of control of murine leukemia virus host-range.

C. Marshall, A. Bernstein, A. Destree, 1976, Journal of supramolecular structure.

Selective depletion of chromosomes in a stable mouse‐chinese hamster hybrid cell line using antisera directed against species‐specific cell surface antigens

C. Marshall, A. Destree, I. Macpherson, 1975, Journal of cellular physiology.

Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil

C. Bluestone, J. Collins, R. W. Hart, 1991, The Pediatric infectious disease journal.

Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.

R. Schwartz, W. Gooch, G. Giguere, 1995, Clinical therapeutics.

Studies on the short-term toxicity of theophylline in rats and mice.

J. E. Heath, D. Bristol, C. Lindamood, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis

J. Schoenberger, M. Drehobl, G. Ruoff, 1995, Antimicrobial agents and chemotherapy.

Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.

D. Bolognesi, T. Matthews, H. Thiel, 1981, Journal of immunology.

Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.

D. Bolognesi, T. Matthews, H. Thiel, 1981, Journal of immunology.

Normal chicken cells (chf-) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus.

R. Montelaro, T. Denny, R. Ishizaki, 1978, Virology.

Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.

W. Gooch, G. Cole, J. Swinehart, 1991, Dermatologica.

IMMUNOTHERAPY OF MURINE LEUKEMIA. VII. PREVENTION OF PASSIVE SERUM THERAPY FRIEND LEUKEMIA VIRUS-INDUCED IMMUNOSUPPRESSION BY

E. Genovesi, J. Collins, Daniella Livnat and, 2006 .

Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.

E. Genovesi, D. Livnat, J. Collins, 1983, Journal of the National Cancer Institute.

Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.

E. Genovesi, F. Sanfilippo, J. Collins, 1981, Journal of the National Cancer Institute.

Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.

S. Pizzo, F. Sanfilippo, J. Collins, 1980, Journal of the National Cancer Institute.

Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay.

D. Bolognesi, T. Denny, J. Collins, 1977, Journal of the National Cancer Institute.

Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.

R. Bettis, E. Riffer, G. Giguere, 1999, Clinical therapeutics.

Cefuroxime axetil in the treatment of sinusitis. A review.

G. E. Pakes, A. Rauch, J. A. Graham, 1994, Archives of family medicine.

IM MUNOTHERAPY OF MURINE LEUKEMIA. I. PROTECTION BY PASSIVE SERUM THERAPY AGAINST FRIEND LEUKEMIA VIRUS-INDUCED DISEASE

R. Metzgar, F. Sanfilippo, J. Collins, 2006 .

Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.

S. Wells, D. Bolognesi, H. Hansen, 1978, Journal of the National Cancer Institute.

Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.

M. Hanna, J. Ihle, D. Bolognesi, 1976, Virology.

Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.

S. Wells, D. Bolognesi, D. Haagensen, 1978, Journal of the National Cancer Institute.

Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.

G. Johnson, J. Collins, D. M. Sackie, 1983, Virology.

Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.

J. Schoenberger, M. Drehobl, G. Ruoff, 1995, Clinical therapeutics.

Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.

E. Genovesi, C. Pettey, J. Collins, 1984, Cancer research.